Pulmonology Department, Centro Hospitalar de Lisboa Central, Lisbon, Portugal.
NOVA Medical School / Faculdade de Ciências Médicas, Lisbon, Portugal.
BMC Pulm Med. 2017 Dec 8;17(1):182. doi: 10.1186/s12890-017-0518-z.
BACKGROUND: Obstructive sleep apnea (OSA) is associated with increased cardiovascular risk. This study aim to assess differences in changes in arterial stiffness of two groups of patients, defined as having daytime sleepiness or not, after continuous positive airway pressure (CPAP) treatment. METHODS: A selected cohort of consecutive male patients, under 65 years old, with moderate to severe OSA and without great number of comorbidities was studied. The diagnosis was confirmed by home respiratory poligraphy. Sleepiness was considered with an Epworth Sleepiness Scale (ESS) > 10. An ambulatory blood pressure (BP) monitoring and carotid-femoral pulse wave velocity (cf-PWV) measurements were performed, before and after four months under CPAP. Compliant patients, sleepy and non-sleepy, were compared using linear mixed effects regression models. A further stratified analysis was performed with non-sleepy patients. RESULTS: Thirty-four patients were recruited, with mean age 55.2 (7.9) years, 38.2% were sleepy, 79.4% with hypertension, 61.8% with metabolic syndrome and 82.4% with dyslipidaemia. In univariable analysis, cf-PWV was strongly related to systolic BP parameters and age, but also to antihypertensive drugs (p = 0.030), metabolic syndrome (p = 0.025) and daytime sleepiness (p = 0.004). Sleepy patients had a more severe OSA, with AHI 44.8 (19.0) vs 29.7 (15.7) events/h (p = 0.018), but sleep study parameters were not associated with cf-PWV values. On multivariable regression, a significant interaction between time (CPAP) and sleepiness (p = 0.033) was found. There was a weak evidence of a cf-PWV reduction after CPAP treatment (p = 0.086), but the effects of treatment differed significantly between groups, with no changes in non-sleepy patients, while in sleepy patients a significant decrease was observed (p = 0.012). Evaluating non-sleepy patients group under CPAP therapy, results showed that both higher pulse pressure (p = 0.001) and lower LDL-cholesterol levels (p = 0.015) at baseline were associated to higher cf-PWV changes. CONCLUSIONS: Patients with daytime sleepiness had a more severe OSA and presented a greater arterial stiffness improvement after CPAP therapy, independently from age and BP. Besides sleepiness, cf-PWV reduction after CPAP therapy was mainly associated to CV risk factors, and less to sleep study parameters. TRIAL REGISTRATION: Clinicaltrials.gov NCT02273089 23.10.2014 retrospectively registered.
背景:阻塞性睡眠呼吸暂停(OSA)与心血管风险增加有关。本研究旨在评估两组患者动脉僵硬变化的差异,这两组患者的定义为是否存在日间嗜睡。
方法:选择了一组年龄在 65 岁以下、中重度 OSA 且合并症数量较少的连续男性患者。通过家庭呼吸多导睡眠图进行诊断。嗜睡通过 Epworth 嗜睡量表(ESS)>10 来判断。在 CPAP 治疗前和治疗后四个月进行了动态血压(BP)监测和颈股脉搏波速度(cf-PWV)测量。使用线性混合效应回归模型比较符合 CPAP 治疗的、嗜睡和非嗜睡患者的结果。对非嗜睡患者进行了进一步的分层分析。
结果:共纳入 34 例患者,平均年龄 55.2(7.9)岁,38.2%的患者有嗜睡,79.4%的患者有高血压,61.8%的患者有代谢综合征,82.4%的患者有血脂异常。单变量分析显示,cf-PWV 与收缩压参数和年龄密切相关,但也与降压药物(p=0.030)、代谢综合征(p=0.025)和日间嗜睡(p=0.004)有关。嗜睡患者的 OSA 更严重,AHI 为 44.8(19.0)vs 29.7(15.7)事件/小时(p=0.018),但睡眠研究参数与 cf-PWV 值无关。多变量回归显示,嗜睡(p=0.033)与 CPAP 治疗时间之间存在显著的交互作用。CPAP 治疗后 cf-PWV 有轻微的降低趋势(p=0.086),但治疗效果在两组之间差异显著,非嗜睡患者无明显变化,而嗜睡患者则有明显的降低(p=0.012)。在对 CPAP 治疗下的非嗜睡患者组进行评估时,结果表明,较高的基础脉压(p=0.001)和较低的 LDL 胆固醇水平(p=0.015)与较高的 cf-PWV 变化有关。
结论:日间嗜睡的患者 OSA 更严重,CPAP 治疗后动脉僵硬改善更明显,这与年龄和血压无关。除了嗜睡外,CPAP 治疗后 cf-PWV 的降低主要与心血管风险因素有关,与睡眠研究参数的关系较小。
试验注册:Clinicaltrials.gov NCT02273089 23.10.2014 回顾性注册。
Vasc Health Risk Manag. 2013
Front Med (Lausanne). 2024-3-7
Diabetol Metab Syndr. 2022-5-12
Medicina (Kaunas). 2021-3-25
Breathe (Sheff). 2016-9
N Engl J Med. 2016-8-28
World J Cardiol. 2015-11-26